Literature DB >> 21404607

[A case of micafungin-hyposensitive Candida glabrata due to FKS2 gene mutation].

Sachiko Inui1, Tatsuya Nakamura, Kouichi Tanabe, Hideaki Ohno, Chihiro Koike, Kazuyuki Okuda, Chiyo Nakata, Hiroko Fujimoto, Hiroe Ohkura, Yoshitsugu Miyazaki, Hakuo Takahashi.   

Abstract

Candida glabrata was continuously isolated in cultured urine samples from a subject with thrombotic thrombocytopenic purpura. Yeast-like fungal phagocytosis found in gram staining led to agents being tested for antifungal susceptibility, revealing hyposensitivity to micafungin (MCFG) of MIC <2 mg/mL. MCFG administered for 10 days failed to cure C. glabrata infection. To clarify why hyposensitivity occurred, we analyzed the FKS gene sequence using the PCR, finding a deficit of 3 bases coding phenylalanine at FKS2 gene amino acid 659. MCFG hyposensitivity may thus occur in long-term candin-class anti-fungal agent treatment. Candin-class agents have potent anti-fungal activity with fewer adverse effects and are widely used clinically. Hyposensitivity due to resistant C. glabrata species showed thus be considered in fungal infection treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21404607     DOI: 10.11150/kansenshogakuzasshi.85.49

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  2 in total

1.  Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC.

Authors:  Takeshi Saraya; Koichi Tanabe; Koji Araki; Shota Yonetani; Hiroshi Makino; Takayasu Watanabe; Naoki Tsujimoto; Saori Takata; Daisuke Kurai; Haruyuki Ishii; Yoshitsugu Miyazaki; Hajime Takizawa; Hajime Goto
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

2.  Gram staining for the treatment of peritonsillar abscess.

Authors:  Yukinori Takenaka; Kazuya Takeda; Tadashi Yoshii; Michiko Hashimoto; Hidenori Inohara
Journal:  Int J Otolaryngol       Date:  2012-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.